Bulletin of the Korean Chemical Society

  • 제33권5호
  • /
  • Pages.1707-1714
  • /
  • 2012
  • /
  • 0253-2964(pISSN)
  • /
  • 1229-5949(eISSN)
대한화학회 (Korean Chemical Society)
권호 표지
DOI QR코드

DOI QR Code

Ligand Based Pharmacophore Identification and Molecular Docking Studies for Grb2 Inhibitors

  • Arulalapperumal, Venkatesh (Department of Biochemistry and Division of Applied Life Science (BK21), Systems and Synthetic Agrobiotech Center (SSAC), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Research Institute of National Science (RINS), Gyeongsang National University (GNU)) ;
  • Sakkiah, Sugunadevi (Department of Biochemistry and Division of Applied Life Science (BK21), Systems and Synthetic Agrobiotech Center (SSAC), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Research Institute of National Science (RINS), Gyeongsang National University (GNU)) ;
  • Thangapandian, Sundarapandian (Department of Biochemistry and Division of Applied Life Science (BK21), Systems and Synthetic Agrobiotech Center (SSAC), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Research Institute of National Science (RINS), Gyeongsang National University (GNU)) ;
  • Lee, Yun-O (Department of Biochemistry and Division of Applied Life Science (BK21), Systems and Synthetic Agrobiotech Center (SSAC), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Research Institute of National Science (RINS), Gyeongsang National University (GNU)) ;
  • Meganathan, Chandrasekaran (Department of Biochemistry and Division of Applied Life Science (BK21), Systems and Synthetic Agrobiotech Center (SSAC), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Research Institute of National Science (RINS), Gyeongsang National University (GNU)) ;
  • Hwang, Swan (Department of Biochemistry and Division of Applied Life Science (BK21), Systems and Synthetic Agrobiotech Center (SSAC), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Research Institute of National Science (RINS), Gyeongsang National University (GNU)) ;
  • Lee, Keun-Woo (Department of Biochemistry and Division of Applied Life Science (BK21), Systems and Synthetic Agrobiotech Center (SSAC), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Research Institute of National Science (RINS), Gyeongsang National University (GNU))
  • 투고 : 2011.10.19
  • 심사 : 2012.02.23
  • 발행 : 2012.05.20
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Grb2 is an adapter protein involved in the signal transduction and cell communication. The Grb2 is responsible for initiation of kinase signaling by Ras activation which leads to the modification in transcription. Ligand based pharmacophore approach was applied to built the suitable pharmacophore model for Grb2. The best pharmacophore model was selected based on the statistical values and then validated by Fischer's randomization method and test set. Hypo1 was selected as a best pharmacophore model based on its statistical values like high cost difference (182.22), lowest RMSD (1.273), and total cost (80.68). It contains four chemical features, one hydrogen bond acceptor (HBA), two hydrophobic (HY), and one ring aromatic (RA). Fischer's randomization results also shows that Hypo1 have a 95% significant level. The correlation coefficient of test set was 0.97 which was close to the training set value (0.94). Thus Hypo1 was used for virtual screening to find the potent inhibitors from various chemical databases. The screened compounds were filtered by Lipinski's rule of five, ADMET and subjected to molecular docking studies. Totally, 11 compounds were selected as a best potent leads from docking studies based on the consensus scoring function and critical interactions with the amino acids in Grb2 active site.

키워드

참고문헌

  1. Jones, D. A.; Benjamin, C. W. Arch. Biochem. Biophy. 1997, 337, 143. https://doi.org/10.1006/abbi.1996.9789
  2. Giubellino, A.; Burke, T. R., Jr.; Bottaro, D. P. Expert. Opin. Ther. Targets. 2008, 12, 1021. https://doi.org/10.1517/14728222.12.8.1021
  3. Lowenstein, E. J.; Daly, R. J.; Batzer, A. G.; Li, W.; Margolis, B.; Lammers, R.; Ullrich, A.; Skolnik, E. Y.; Sagi, D. B.; Schlessinger, J. Cell 1992, 70, 431. https://doi.org/10.1016/0092-8674(92)90167-B
  4. Takemoto, Y.; Furuta, M.; Sato, M.; Findell, P. R.; Ramble, W.; Hashimoto, Y. J. Immunol. 1998, 161, 625.
  5. Feng, G. S.; Ouyang, Y. B.; Hu, D. P.; Shi, Z. Q.; Gentz, R.; Ni, J. J. Biol. Chem. 1996, 27, 12129.
  6. Lakshmi, S.; Cao, T.; King, C. R. Int. J. Cancer 1997, 70, 208. https://doi.org/10.1002/(SICI)1097-0215(19970117)70:2<208::AID-IJC12>3.0.CO;2-E
  7. Giubellino, A.; Yang, G.; Lee, S.; Lee, M. J.; Vasselli, J. R.; Medepalli, S.; Trepel, J. B.; Burke, T. R., Jr.; Bottaro, D. P. Cancer Res. 2007, 67, 6012. https://doi.org/10.1158/0008-5472.CAN-07-0022
  8. Li, N.; Batzer, A.; Daly, R.; Yajnik, V.; Skolnik, E.; Chardin, P.; Sagi, D. B.; Margolis, B.; Schlessinger, J. Nature 1993, 363, 85. https://doi.org/10.1038/363085a0
  9. Lipinski, C. A. J. Pharmacol. Toxicol. Methods 2000, 44, 235. https://doi.org/10.1016/S1056-8719(00)00107-6
  10. Clark, S. G.; Stern, M. J.; Horvitz, H. R. Nature 1992, 352, 340.
  11. Buday, L.; Downward, J. Cell 1993, 73, 611. https://doi.org/10.1016/0092-8674(93)90146-H
  12. Ridely, A. J.; Hall, A. Cell 1992, 70, 389. https://doi.org/10.1016/0092-8674(92)90163-7
  13. Ridely, A. J.; Peterson, H. F.; Johnston, C. L.; Diekmann, D.; Hall, A. Cell 1992, 70, 401. https://doi.org/10.1016/0092-8674(92)90164-8
  14. Skolnik, E. Y.; Lee, C. H.; Batzar, A.; Vicentini, L. M.; Zhou, M.; Daly, R.; Myers, M. J., Jr.; Backer, J. M.; Ullrich, A.; White, M. F.; Schlessinger, J. Embo. J. 1993, 12, 1929.
  15. Phan, J.; Shi, Z. D.; Waugh, D. S. J. Mol. Biol. 2005, 353, 104. https://doi.org/10.1016/j.jmb.2005.08.037
  16. Moeller, S. J.; Head, E. D.; Sheaff, R. J. Mol. Cellul. Biol. 2003, 23, 3735. https://doi.org/10.1128/MCB.23.11.3735-3752.2003
  17. Chen, C. H.; Chen, M. K.; Jeng, K. C. G.; Lung, F. D. T. Pro. Pep. Lett. 2010, 17, 44. https://doi.org/10.2174/092986610789909421
  18. Furet, P.; Garcia, E. C.; Gay, B.; Schoepfer, J.; Zeller, M.; Rahuel, J. J. Med. Chem. 1999, 42, 2358. https://doi.org/10.1021/jm991013u
  19. ACD/Labs.com Software. http://www.acdlabs.com/home/
  20. Catalyst, Version 4.10. Accelrys Inc. San Diego, CA, USA, 2005.
  21. Song, Y. L.; Peach, M. L.; Roller, P. P.; Qiu, S.; Wang, S.; Long, Y. Q. J. Med. Chem. 2006, 49, 1585. https://doi.org/10.1021/jm050910x
  22. Sundarapandian, T.; Shalini, J.; Sugunadevi, S.; Lee, K. W. J. Chem. Inf. Model. 2011, 51, 33. https://doi.org/10.1021/ci1002813
  23. Sugunadevi, S.; Sundarapandian, T.; Shalini, J.; Yong, J. K.; Lee, K. W. Euro. J. Med. Chem. 2010, 45, 2132. https://doi.org/10.1016/j.ejmech.2010.01.016
  24. Rester, U. Curr. Opin. Drug Discov. Devel. 2008, 11, 559.
  25. Terstappen, G. C.; Reggiani, A. Trends Pharm. Sci. 2001, 22, 0165.
  26. Lee, Y.; Bharatham, N.; Bharatham, K.; Lee, K. W. Bull. Korean. Chem. Soc. 2007, 28, 561. https://doi.org/10.5012/bkcs.2007.28.4.561
  27. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Adv. Drug Del. Rev. 2001, 46, 3. https://doi.org/10.1016/S0169-409X(00)00129-0
  28. Lengauer, T.; Rarey, M. Curr. Opin. Struct. Biol. 1996, 6, 402. https://doi.org/10.1016/S0959-440X(96)80061-3
  29. Helen, M. B.; John, W. B.; Zukang, P.; Gary, G.; Bhat, T. N.; Helge, W.; Shindyalov, L. N.; Bourne, P. E. Nucl. Acid Res. 2000, 28, 235. https://doi.org/10.1093/nar/28.1.235
  30. Jain, A. N. J. Comput. Aid. Mol. Des. 1996, 10, 427. https://doi.org/10.1007/BF00124474
  31. Bohm, H. J. J. Comput. Aid. Mol. Des. 1994, 8, 243. https://doi.org/10.1007/BF00126743
  32. Bohm, H. J. J Comput. Aid. Mol. Des. 1998, 12, 309. https://doi.org/10.1023/A:1007999920146
  33. Schoepfer, J.; Fretz, H.; Gay, B.; Furet, P.; Echeverria, C.G.; End, N. G. Bioorg. Med. Chem. Lett. 1999, 9, 221. https://doi.org/10.1016/S0960-894X(98)00701-X
  34. Sugunadevi, S.; Navaneethakrishnan, K.; Poornima, G.; Sundarapandian, T.; Yuno, L.; Songmi, K.; Suh, J. K.; Kim, H. H.; Lee, K. W. Bull. Korean. Chem. Soc. 2009, 30, 1152. https://doi.org/10.5012/bkcs.2009.30.5.1152
  35. Shalini, J.; Sundarapandian, T.; Sugunadevi, S.; Lee, K. W. Euro. J. Med. Chem. 2010, 45, 4004. https://doi.org/10.1016/j.ejmech.2010.05.057
  36. Kitchen, D. B.; Decorner, H.; Furr, J. R.; Bajorath, J. Nature. Rev. Drug Disco. 2004, 3, 935. https://doi.org/10.1038/nrd1549
  37. Totrov, M.; Ababyan, R. Curr. Opin. Struct. 2008, 18, 178. https://doi.org/10.1016/j.sbi.2008.01.004
  38. Venkatachalam, C. M.; Jiang, X.; Oldfield, T.; Waldman, M. J. Mol. Graph. Model. 2003, 21, 289. https://doi.org/10.1016/S1093-3263(02)00164-X

피인용 문헌

  1. Automated docking for novel drug discovery vol.8, pp.7, 2013, https://doi.org/10.1517/17460441.2013.794780
  2. Docking Simulation of the Binding Interactions of Saxitoxin Analogs Produced by the Marine Dinoflagellate Gymnodinium catenatum to the Voltage-Gated Sodium Channel Nav1.4 vol.8, pp.5, 2016, https://doi.org/10.3390/toxins8050129